Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+399K
-
Total reported value, excl. options
-
$636M
-
Value change
-
+$13.2M
-
Put/Call ratio
-
0.54
-
Number of buys
-
63
-
Number of sells
-
-46
-
Price
-
$33.09
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2021
149 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q3 2021.
TransMedics Group, Inc. - Common Stock (TMDX) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
of 33.9M outstanding shares and own 56.65% of the company stock.
Largest 10 shareholders include FMR LLC (4.15M shares), BlackRock Inc. (1.85M shares), MACQUARIE GROUP LTD (1.62M shares), CREDIT SUISSE AG/ (1.52M shares), Sandhill Capital Partners LLC (1.44M shares), VANGUARD GROUP INC (1.26M shares), KPCB XIII Associates, LLC (923K shares), STATE STREET CORP (801K shares), Bellevue Group AG (581K shares), and GEODE CAPITAL MANAGEMENT, LLC (437K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.